CORY DAVIS: Open Payments
NPI 1326453150 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 19 payments from 10 companies in 2025. Trend: 2023 $158 · 2024 $0 · 2025 $815
Food & beverage: $797Education: $18
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $265 |
| AstraZeneca Pharmaceuticals LP | 5 | $201 |
| Edwards Lifesciences Corporation | 1 | $165 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| PFIZER INC. | 1 | $40 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Dexcom, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: SAPIEN 3 Ultra RESILIA, AIRSUPRA, Ozempic, ADSTILADRIN, TRELEGY ELLIPTA, BREZTRI, Dexcom G6 Transmitter, FARXIGA.
Industry payments across OH — which companies pay providers there.
